Literature DB >> 7371020

Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil.

P M Schwartz, J M Dunigan, J C Marsh, R E Handschumacher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7371020

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  5-fluorocytosine susceptibility of pathogenic fungi in the presence of allopurinol: potential for improving the therapeutic index of 5-fluorocytosine.

Authors:  T M Kerkering; P M Schwartz; A Espinel-Ingroff; P J Turek; R B Diasio
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

2.  Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration.

Authors:  C P Spears; B G Gustavsson; R Frösing
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 3.  Conceptual changes in cancer chemotherapy: from an oral fluoropyrimidine prodrug, UFT, to a novel oral fluoropyrimidine prodrug, S-1, and low-dose FP therapy in Japan.

Authors:  T Shirasaka; S Yamamitsu; A Tsuji; T Taguchi
Journal:  Invest New Drugs       Date:  2000-11       Impact factor: 3.850

4.  Concurrent allopurinol and 5-fluorouracil: 5-fluoro-2'-deoxyuridylate formation and thymidylate synthase inhibition in rat colon carcinoma and in regenerating rat liver.

Authors:  M Berne; B Gustavsson; O Almersjö; C P Spears; J Waldenström
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 5.  Cancer therapy and oral mucositis. An appraisal of drug prophylaxis.

Authors:  C J Verdi
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

6.  Chemical toxicity of the granulocyte.

Authors:  J C Marsh
Journal:  Environ Health Perspect       Date:  1981-06       Impact factor: 9.031
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.